Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone.
Oakes M, Arastu A, Kato C, Somers J, Holly HD, Elstrott BK, Dy GW, Kohs TCL, Patel RR, McCarty OJT, DeLoughery TG, Milano C, Raghunathan V, Shatzel JJ.
Oakes M, et al. Among authors: shatzel jj.
Thromb Res. 2021 Nov;207:96-98. doi: 10.1016/j.thromres.2021.09.005. Epub 2021 Sep 20.
Thromb Res. 2021.
PMID: 34592628
Free PMC article.